{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:10:58Z","timestamp":1791317458388,"version":"4.3.1"},"reference-count":34,"publisher":"The Endocrine Society","issue":"4","funder":[{"DOI":"10.13039\/501100009240","name":"Sveriges Kommuner och Landsting","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009240","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007212","name":"V\u00e4stra G\u00f6talandsregionen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007212","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007212","name":"V\u00e4stra G\u00f6talandsregionen","doi-asserted-by":"publisher","award":["ALFGBG-719531"],"award-info":[{"award-number":["ALFGBG-719531"]}],"id":[{"id":"10.13039\/100007212","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2015-02561"],"award-info":[{"award-number":["2015-02561"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>Patients with type 1 diabetes mellitus (T1DM) have an increased risk of Addison disease (AD) development, but prediction of those at risk is not possible.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To determine whether there are early clinical indicators that may denote the development of AD in adults with T1DM.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>Observational, matched-cohort study.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Setting<\/jats:title>\n                  <jats:p>Patient data from Swedish national registries [National Diabetes Register (NDR), Inpatient Register, and Prescription Drug Register].<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Participants<\/jats:title>\n                  <jats:p>All patients with T1DM diagnosed with concomitant AD (n = 66) among the 36,514 adult patients with T1DM in the NDR between 1998 and 2013. Each case was matched to five controls with T1DM alone (n = 330).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Main Outcome Measures<\/jats:title>\n                  <jats:p>Clinical data and drug prescriptions were assessed prior to baseline (inclusion into the study) and prior to AD diagnosis. Analysis of covariance and estimated group proportions were used for comparisons.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Prior to baseline, cases had a higher frequency of thyroid\/antithyroid drug prescription than controls (9.1% vs 1.8%). Prior to AD diagnosis, cases had higher frequencies of diabetic retinopathy (12.1% vs 2.1%), infections requiring hospital admission (16.7% vs 2.1%), thyroid\/antithyroid drug prescription (28.8% vs 7.0%), and glucagon prescription (18.2% vs 6.4%). There was no difference in glycated Hb between the groups prior to baseline or prior to AD diagnosis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>These data suggest that medical treatment of thyroid disease, a severe infection, and glucagon prescription for severe hypoglycemia should raise the suspicion of AD development in adults with T1DM. Development of diabetic retinopathy might also be associated with glucocorticoid deficiency and the development of AD among patients with T1DM.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/jc.2018-02064","type":"journal-article","created":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T22:33:13Z","timestamp":1542839593000},"page":"1148-1157","source":"Crossref","is-referenced-by-count":7,"title":["Early Clinical Indicators of Addison Disease in Adults With Type 1 Diabetes: A Nationwide, Observational, Cohort Study"],"prefix":"10.1210","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1660-1973","authenticated-orcid":false,"given":"Dimitrios","family":"Chantzichristos","sequence":"first","affiliation":[{"name":"Department of Internal Medicine and Clinical Nutrition, Institute of Medicine at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"},{"name":"Department of Endocrinology-Diabetes-Metabolism, Sahlgrenska University Hospital, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4153-5493","authenticated-orcid":false,"given":"Anders","family":"Persson","sequence":"additional","affiliation":[{"name":"National Diabetes Register at Centre of Registers, Department of Medicine, University of Gothenburg, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4028-8945","authenticated-orcid":false,"given":"Mervete","family":"Miftaraj","sequence":"additional","affiliation":[{"name":"National Diabetes Register at Centre of Registers, Department of Medicine, University of Gothenburg, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2569-4160","authenticated-orcid":false,"given":"Bj\u00f6rn","family":"Eliasson","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Clinical Nutrition, Institute of Medicine at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"},{"name":"Department of Endocrinology-Diabetes-Metabolism, Sahlgrenska University Hospital, Gothenburg, Sweden"},{"name":"National Diabetes Register at Centre of Registers, Department of Medicine, University of Gothenburg, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8121-2045","authenticated-orcid":false,"given":"Ann-Marie","family":"Svensson","sequence":"additional","affiliation":[{"name":"National Diabetes Register at Centre of Registers, Department of Medicine, University of Gothenburg, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3484-8440","authenticated-orcid":false,"given":"Gudmundur","family":"Johannsson","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Clinical Nutrition, Institute of Medicine at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"},{"name":"Department of Endocrinology-Diabetes-Metabolism, Sahlgrenska University Hospital, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2018,11,21]]},"reference":[{"issue":"10146","key":"2020071622324574300_B1","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0140-6736(18)31506-X","article-title":"Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study","volume":"392","author":"Rawshani","year":"2018","journal-title":"Lancet"},{"issue":"21","key":"2020071622324574300_B2","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1056\/NEJMoa1408214","article-title":"Glycemic control and excess mortality in type 1 diabetes","volume":"371","author":"Lind","year":"2014","journal-title":"N Engl J Med"},{"issue":"12","key":"2020071622324574300_B3","doi-asserted-by":"crossref","first-page":"4849","DOI":"10.1210\/jc.2006-0076","article-title":"Premature mortality in patients with Addison\u2019s disease: a population-based study","volume":"91","author":"Bergthorsdottir","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2020071622324574300_B4","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/j.1365-2265.2008.03340.x","article-title":"Increased death risk and altered cancer incidence pattern in patients with isolated or combined autoimmune primary adrenocortical insufficiency","volume":"69","author":"Bensing","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5362","key":"2020071622324574300_B5","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1136\/bmj.2.5362.887","article-title":"Eighty-six cases of Addison\u2019s disease","volume":"2","author":"Dunlop","year":"1963","journal-title":"BMJ"},{"issue":"2","key":"2020071622324574300_B6","doi-asserted-by":"crossref","first-page":"183.e1","DOI":"10.1016\/j.amjmed.2009.06.030","article-title":"Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease","volume":"123","author":"Boelaert","year":"2010","journal-title":"Am J Med"},{"issue":"3","key":"2020071622324574300_B7","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1210\/edrv.23.3.0466","article-title":"Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction","volume":"23","author":"Betterle","year":"2002","journal-title":"Endocr Rev"},{"issue":"6","key":"2020071622324574300_B8","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1046\/j.1365-2265.2002.t01-1-01552.x","article-title":"High prevalence and increasing incidence of Addison\u2019s disease in western Norway","volume":"56","author":"L\u00f8v\u00e5s","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"12","key":"2020071622324574300_B9","doi-asserted-by":"crossref","first-page":"4931","DOI":"10.1210\/jc.2016-2478","article-title":"Autoimmune diseases in children and adults with type 1 diabetes from the T1D Exchange Clinic Registry","volume":"101","author":"Hughes","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2020071622324574300_B10","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1530\/EJE-17-0751","article-title":"Incidence, prevalence and seasonal onset variation of Addison\u2019s disease among persons with type 1 diabetes mellitus: nationwide, matched cohort studies","volume":"178","author":"Chantzichristos","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2020071622324574300_B11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1530\/EJE-16-0657","article-title":"Mortality in patients with diabetes mellitus and Addison\u2019s disease: a nationwide, matched, observational cohort study","volume":"176","author":"Chantzichristos","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"2020071622324574300_B12","first-page":"3507","article-title":"Levels of adrenocortical autoantibodies correlate with the degree of adrenal dysfunction in subjects with preclinical Addison\u2019s disease","volume":"83","author":"Laureti","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2020071622324574300_B13","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/MAJ.0b013e3181db6b7a","article-title":"Delayed diagnosis of adrenal insufficiency is common: a cross-sectional study in 216 patients","volume":"339","author":"Bleicken","year":"2010","journal-title":"Am J Med Sci"},{"issue":"5","key":"2020071622324574300_B14","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1210\/jc.2012-3561","article-title":"Drug prescription patterns in patients with Addison\u2019s disease: a Swedish population-based cohort study","volume":"98","author":"Bj\u00f6rnsdottir","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2020071622324574300_B15","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/joim.12699","article-title":"Clues for early detection of autoimmune Addison\u2019s disease - myths and realities","volume":"283","author":"Saevik","year":"2018","journal-title":"J Intern Med"},{"issue":"7","key":"2020071622324574300_B16","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s00125-014-3225-9","article-title":"The incidence of diabetes among 0-34 year olds in Sweden: new data and better methods","volume":"57","author":"Rawshani","year":"2014","journal-title":"Diabetologia"},{"issue":"1","key":"2020071622324574300_B17","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/1471-2458-11-450","article-title":"External review and validation of the Swedish national inpatient register","volume":"11","author":"Ludvigsson","year":"2011","journal-title":"BMC Public Health"},{"key":"2020071622324574300_B18","doi-asserted-by":"crossref","first-page":"S291","DOI":"10.1016\/S0168-8227(14)70732-6","article-title":"Diabetes care--improvement through measurement","volume":"106","author":"Eliasson","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"issue":"7","key":"2020071622324574300_B19","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/pds.1294","article-title":"The new Swedish Prescribed Drug Register--opportunities for pharmacoepidemiological research and experience from the first six months","volume":"16","author":"Wettermark","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"2020071622324574300_B20","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1530\/EJE-12-0879","article-title":"Increased use of antimicrobial agents and hospital admission for infections in patients with primary adrenal insufficiency: a cohort study","volume":"168","author":"Smans","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"2020071622324574300_B21","doi-asserted-by":"crossref","first-page":"4843","DOI":"10.1210\/jc.2016-2221","article-title":"Exploring inpatient hospitalizations and morbidity in patients with adrenal insufficiency","volume":"101","author":"Stewart","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2020071622324574300_B22","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S2213-8587(17)30398-4","article-title":"Effect of once-daily, modified-release hydrocortisone versus standard glucocorticoid therapy on metabolism and innate immunity in patients with adrenal insufficiency (DREAM): a single-blind, randomised controlled trial","volume":"6","author":"Isidori","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"2020071622324574300_B23","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1530\/EJE-16-0969","article-title":"Primary adrenal insufficiency is associated with impaired natural killer cell function: a potential link to increased mortality","volume":"176","author":"Bancos","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"2020071622324574300_B24","doi-asserted-by":"crossref","first-page":"4264","DOI":"10.1210\/jc.2017-01324","article-title":"Visceral fat and novel biomarkers of cardiovascular disease in patients with Addison\u2019s disease: a case-control study","volume":"102","author":"Bergthorsdottir","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2020071622324574300_B25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ajpath.2016.08.022","article-title":"Mechanistic insights into pathological changes in the diabetic retina: implications for targeting diabetic retinopathy","volume":"187","author":"Roy","year":"2017","journal-title":"Am J Pathol"},{"issue":"3","key":"2020071622324574300_B26","doi-asserted-by":"crossref","first-page":"556","DOI":"10.2337\/dc11-1909","article-title":"Global prevalence and major risk factors of diabetic retinopathy","volume":"35","author":"Yau","year":"2012","journal-title":"Diabetes Care"},{"issue":"6","key":"2020071622324574300_B27","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1530\/EJE-08-1003","article-title":"Altered insulin requirement in patients with type 1 diabetes and primary adrenal insufficiency receiving standard glucocorticoid replacement therapy","volume":"160","author":"Elbelt","year":"2009","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2020071622324574300_B28","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/cen.13043","article-title":"Addison\u2019s disease with polyglandular autoimmunity carries a more than 2\u00b75-fold risk for adrenal crises: German Health insurance data 2010-2013","volume":"85","author":"Meyer","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"2020071622324574300_B29","first-page":"379","article-title":"Clinical and immunological characteristics of autoimmune Addison\u2019s disease: a nationwide Swedish multicenter study","volume":"102","author":"Dalin","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2020071622324574300_B30","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1210\/jc.2017-01928","article-title":"Primary adrenal insufficiency: managing mineralocorticoid replacement therapy","volume":"103","author":"Esposito","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2020071622324574300_B31","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.2337\/db10-0862","article-title":"Cause-specific mortality trends in a large population-based cohort with long-standing childhood-onset type 1 diabetes","volume":"59","author":"Secrest","year":"2010","journal-title":"Diabetes"},{"issue":"10","key":"2020071622324574300_B32","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1210\/jc.2007-0685","article-title":"Impaired subjective health status in 256 patients with adrenal insufficiency on standard therapy based on cross-sectional analysis","volume":"92","author":"Hahner","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2020071622324574300_B33","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1046\/j.1365-2265.2002.01466.x","article-title":"Subjective health status in Norwegian patients with Addison\u2019s disease","volume":"56","author":"L\u00f8v\u00e5s","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"11","key":"2020071622324574300_B34","first-page":"4201","article-title":"Glucocorticoid replacement is permissive for rapid eye movement sleep and sleep consolidation in patients with adrenal insufficiency","volume":"85","author":"Garc\u00eda-Borreguero","year":"2000","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/104\/4\/1148\/27985705\/jc.2018-02064.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/104\/4\/1148\/27985705\/jc.2018-02064.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T10:56:04Z","timestamp":1594983364000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/104\/4\/1148\/5193469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,21]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2018-02064","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,4]]},"published":{"date-parts":[[2018,11,21]]}}}